Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy (Q28477147)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy	scientific article

Statements

scholarly article

0 references

Pharmacologic modulation of serine/threonine phosphorylation highly sensitizes PHEO in a MPC cell and mouse model to conventional chemotherapy (English)

0 references

0 references

1 reference

based on heuristic

inferred from title

phosphorylation

1 reference

based on heuristic

inferred from title

7

object named as

Karel Pacak

0 references

author name string

Lucia Martiniova

1

0 references

Jie Lu

2

0 references

Jeffrey Chiang

3

0 references

Marcelino Bernardo

4

0 references

Russell Lonser

5

0 references

Zhengping Zhuang

6

0 references

language of work or name

0 references

publication date

14 February 2011

0 references

0 references

6

0 references

2

0 references

e14678

0 references

copyright license

Creative Commons Attribution 4.0 International

14 February 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

describes a project that uses

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3038858/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

Cell cycle kinases as therapeutic targets for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

19 March 2017

Cell cycle, CDKs and cancer: a changing paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

19 March 2017

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

19 March 2017

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

19 March 2017

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

19 March 2017

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

7 April 2017

Principles of cancer therapy: oncogene and non-oncogene addiction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

7 April 2017

Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Impaired DNA damage response--an Achilles' heel sensitizing cancer to chemotherapy and radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Clinical and molecular progress in hereditary paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Volumetric neuroimage analysis extensions for the MIPAV software package

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Mitotic arrest and cell fate: why and how mitotic inhibition of transcription drives mutually exclusive events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Regulation of Polo-like kinase 1 by DNA damage in mitosis. Inhibition of mitotic PLK-1 by protein phosphatase 2A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Phaeochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Selective killing of transformed baby hamster kidney (BHK) cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

29 September 2017

Revealing global regulatory perturbations across human cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3038858

2 June 2018

Genetic testing in pheochromocytoma or functional paraganglioma

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

Clinical utility of temozolomide in the treatment of malignant paraganglioma: a preliminary report.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

Enhancement of cancer chemotherapy by simultaneously altering cell cycle progression and DNA-damage defenses through global modification of the serine/threonine phospho-proteome

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

Polo-like kinase-1 is a target of the DNA damage checkpoint

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0014678

21 January 2018

Catecholaminergic inhibition by hypercortisolemia in the paraventricular nucleus of conscious rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21339823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pheochromocytoma: time to stamp out "malignancy"?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21339823

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0014678

0 references

2011PLoSO...614678M

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28477147&oldid=1869603235"